Browse All

Current Filters

CLEAR FILTER x

TITLE

A Patient with Late-Onset Cerebellar Ataxia and a Novel FAT2 Gene Variant Concerning for Spinocerebellar Ataxia Type 45: A Case Report

Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity

GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease (AD)